Pricing Log in Create free account

Incannex Healthcare Inc. (IXHL) vs Talphera, Inc. (TLPH)

Incannex Healthcare Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $55.5M against $36.1M — 1.5× the size. Across the 12 metrics below, Incannex Healthcare Inc. leads on 8 and Talphera, Inc. on 4.

Valuation

Metric IXHL TLPH Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 21.06 191.48 2.11
P/B 0.49 5.66 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA 1.36 n/m 12.58
EV/Sales (19.90) 166.32 2.73
Earnings yield (60.71%) (25.00%) (4.38%)
Free cash flow yield (39.17%) (11.83%) 0.00%

Profitability

Metric IXHL TLPH Drug Manufacturers Specialty & Generic median
Gross margin (0.10%) 100.00% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.80%) (143.36%) (0.40%)
Return on assets (41.32%) (69.60%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IXHL TLPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (73.07%) 10.01%
EPS growth (last fiscal year) 95.91% 32.00% 49.06%
Revenue growth, 5-year CAGR (29.64%) (58.55%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IXHL TLPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 48.81 4.29 2.31
Net debt to EBITDA 2.97 1.50 0.97

Dividend

Metric IXHL TLPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric IXHL TLPH Drug Manufacturers Specialty & Generic median
Market cap 36.12m 55.54m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack